ETFs most similar to PBE
The funds whose holdings overlap Invesco Biotechnology & Genome ETF the most, by weight. as of Oct 8, 2026issuer data
By holdings overlap
| Fund | Category | Overlap with PBE | Fee | Assets | 1Y | Yield | Compare |
|---|---|---|---|---|---|---|---|
| PBEInvesco Biotechnology & Genome ETF | Biotech & Health Innovation | — | 0.58% | $422M | +34.5% | 1.38% | |
| FBTFirst Trust NYSE Arca Biotechnology Index Fund | Biotech & Health Innovation | 45% | 0.55% | $2.9B | +41.3% | — | side by side |
| BBHVanEck Biotech ETF | Biotech & Health Innovation | 43% | 0.35% | $485M | +36.9% | 0.40% | side by side |
| IBBiShares Biotechnology ETF | Biotech & Health Innovation | 42% | 0.44% | $10.8B | +35.9% | 0.17% | side by side |
| IBBQInvesco Nasdaq Biotechnology ETF | Biotech & Health Innovation | 39% | 0.19% | $106M | +35.5% | 1.13% | side by side |
| FTXHFirst Trust Nasdaq Pharmaceuticals ETF | Health Care | 33% | 0.60% | $1.1B | +40.7% | 0.70% | side by side |
Overlap is the sum of the smaller of the two weights across every shared holding. Try any combination in the overlap tool.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.